Editorial ArticleLife Sciences
From biopsy bottlenecks to biomarker breakthroughs - how non-invasive tools are reshaping MASH trials
In this guest editorial, Dr. Megan O’Shaughnessy of ICON plc shares how non-invasive testing has the potential to transform the management of metabolic liver disease
